Influence of<i>Saccharomyces boulardii</i>on the intestinal permeability of patients with Crohn's disease in remission

Abstract

Patients with CD in remission present alterations in the integrity of the intestinal mucosal barrier according to lactulose/mannitol ratio. S. boulardii added to baseline therapy improved intestinal permeability in these patients, even though complete normalization was not achieved.